Guliyev M, Alan Özkan, Fidan MC, Abbasov H, Cebeci S, Aliyev V, et al. Evaluating the Prognostic Role of Pan-Immune-Inflammation Value in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab. Cerrahpaşa Medical Journal [Internet]. 2025 Sep. 29 [cited 2025 Dec. 18];49(1):1-9. Available from: https://cerrahpasamedj.org/index.php/pub/article/view/965